Manufacturing and Process

Cyma Builders completely renovated an exi sting pharmaceutical production space for August Bioservices, helping to facilitate their future business goals.

Cyma Builders successfully completed the GMP production suites for one of our confidential clients! We are proud to share that our team was not only able to accomplish the expansion successfully, but also overcome the project’s unique challenges in a seamless way.

Cyma Builders and Construction Managers were retained by a confidential client to construct a new pilot plant at their existing PA facility....

Cyma Builders and Construction Managers were retained by a confidential client to construct a new manufacturing suite with a corresponding compounding suite at their New Jersey facility....

Three phase renovation to Lonza's existing Powder Media suite to meet GMP compliance, improve workflows and optimize functionality...

Cyma Builders and Construction Managers were retained by DPT Laboratories to construct a new small volume parenteral (SVP) manufacturing suite...

Local to our west coast presence, Cyma Builders & Construction Managers completed a $500,000 Oven Room construction project for a confidential Fortune 500 Pharmaceutical firm in Vacaville, California.

Cyma Builders was selected as the construction manager by a Pharmaceutical Company to implement their Capacity Expansion Masterplan. The...

Cyma Builders & Construction Managers was selected by DPT Laboratories for construction a multi-component project to build a new Wash...

Cyma Builders was selected as the construction manager for a Weigh/Dispense/Blend Suite to faciltiate relocation of OSD manufacturing operations to...

Cyma Builders & Construction Managers have been retained by Jacobus Pharmaceuticals, Inc. to provide Pre-Construction, Construction, and Post-Construction...

Cyma Builders & Construction Managers were retained to provide pre-construction and construction management services for DPT Laboratories...

This project consisted of the renovation of an existing 19,000 SF non-GMP research and development facility to a new cGMP Aseptic...